{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:19:11Z","timestamp":1790399951461,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272043"],"award-info":[{"award-number":["82272043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20758"],"award-info":[{"award-number":["U24A20758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171987"],"award-info":[{"award-number":["82171987"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004767","name":"University of Science and Technology Liaoning","doi-asserted-by":"publisher","award":["2024-MSLH-547"],"award-info":[{"award-number":["2024-MSLH-547"]}],"id":[{"id":"10.13039\/501100004767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","award":["Liaoning Revitalization Talents Program"],"award-info":[{"award-number":["Liaoning Revitalization Talents Program"]}],"id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00259-025-07495-6","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:00:33Z","timestamp":1754550033000},"page":"786-799","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fibroblast activation Protein-Targeted PET\/CT using [18\u00a0F]FAP-2286 for the evaluation of lung cancer: A comparative study with [18\u00a0F]FDG PET\/CT"],"prefix":"10.1007","volume":"53","author":[{"given":"Yu","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1109-0980","authenticated-orcid":false,"given":"Xuena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"7495_CR1","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1097\/rlu.0000000000005348","volume":"49","author":"M Kiani","year":"2024","unstructured":"Kiani M, Jokar S, Hassanzadeh L, Behnammanesh H, Bavi O, Beiki D, et al. Recent clinical implications of FAPI: imaging and therapy. Clin Nucl Med. 2024;49:e538\u201356. https:\/\/doi.org\/10.1097\/rlu.0000000000005348.","journal-title":"Clin Nucl Med"},{"key":"7495_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12091964","author":"K Naito","year":"2024","unstructured":"Naito K, Sangai T, Yamashita K. CAF-associated genes in breast cancer for novel therapeutic strategies. Biomedicines. 2024. https:\/\/doi.org\/10.3390\/biomedicines12091964.","journal-title":"Biomedicines"},{"key":"7495_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/ppo.0000000000000719","volume":"30","author":"M Nakayama","year":"2024","unstructured":"Nakayama M, Hope TA, Salavati A. Diagnostic and therapeutic application of fibroblast activation protein inhibitors in oncologic and nononcologic diseases. Cancer J (Sudbury Mass). 2024;30:210\u20137. https:\/\/doi.org\/10.1097\/ppo.0000000000000719.","journal-title":"Cancer J (Sudbury Mass)"},{"key":"7495_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-13153-1","volume":"24","author":"Z Liang","year":"2024","unstructured":"Liang Z, Peng H, Li W, Liu Z. Head-to-head study of [(18)F]FAPI-04 PET\/CT and [(18)F]FDG PET\/CT for non-invasive assessment of liver cancer and its immunohistochemical markers. BMC Cancer. 2024;24: 1378. https:\/\/doi.org\/10.1186\/s12885-024-13153-1.","journal-title":"BMC Cancer"},{"key":"7495_CR5","doi-asserted-by":"publisher","unstructured":"Michalski K, Kosmala A, Hartrampf PE, Heinrich M, Serfling SE, Schl\u00f6telburg W, et al. [(18)F]FDG and [(68)Ga]Ga-FAPI-04-Directed imaging for outcome prediction in patients with High-Grade neuroendocrine neoplasms. J Nuclear Medicine: Official Publication Soc Nuclear Med. 2024. https:\/\/doi.org\/10.2967\/jnumed.124.268288.","DOI":"10.2967\/jnumed.124.268288"},{"key":"7495_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-024-01993-7","author":"M Watanabe","year":"2024","unstructured":"Watanabe M, Fendler WP, Grafe H, Hirmas N, Hamacher R, Lanzafame H, et al. Head-to-head comparison of (68)Ga-FAPI-46 PET\/CT, (18)F-FDG PET\/CT, and contrast-enhanced CT for the detection of various tumors. Ann Nucl Med. 2024. https:\/\/doi.org\/10.1007\/s12149-024-01993-7.","journal-title":"Ann Nucl Med"},{"key":"7495_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2967\/jnumed.120.259192","volume":"63","author":"RP Baum","year":"2022","unstructured":"Baum RP, Schuchardt C, Singh A, Chantadisai M, Robiller FC, Zhang J, et al. Feasibility, biodistribution, and preliminary dosimetry in Peptide-Targeted radionuclide therapy of diverse adenocarcinomas using (177)Lu-FAP-2286: First-in-Humans results. Journal of nuclear medicine: official publication. Soc Nuclear Med. 2022;63:415\u201323. https:\/\/doi.org\/10.2967\/jnumed.120.259192.","journal-title":"Soc Nuclear Med"},{"key":"7495_CR8","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2967\/jnumed.123.267281","volume":"65","author":"B Kline","year":"2024","unstructured":"Kline B, Yadav S, Seo Y, Ippisch RC, Castillo J, Aggarwal RR, et al. (68)Ga-FAP-2286 PET of solid tumors: biodistribution, dosimetry, and comparison with (18)F-FDG. Journal of nuclear medicine: official publication. Soc Nuclear Med. 2024;65:938\u201343. https:\/\/doi.org\/10.2967\/jnumed.123.267281","journal-title":"Soc Nuclear Med"},{"key":"7495_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1007\/s00259-024-06635-8","volume":"51","author":"SS Banihashemian","year":"2024","unstructured":"Banihashemian SS, Divband G, Pirayesh E, Nikkholgh B, Amini H, Shahrnoy AA, et al. [(68)Ga]Ga-FAP-2286, a novel promising theragnostic approach for PET\/CT imaging in patients with various type of metastatic cancers. Eur J Nucl Med Mol Imaging. 2024;51:1981\u20138. https:\/\/doi.org\/10.1007\/s00259-024-06635-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7495_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.122.264544","volume":"64","author":"Y Pang","year":"2023","unstructured":"Pang Y, Zhao L, Meng T, Xu W, Lin Q, Wu H, et al. PET imaging of fibroblast activation protein in various types of cancer using (68)Ga-FAP-2286: comparison with (18)F-FDG and (68)Ga-FAPI-46 in a Single-Center, prospective study. Journal of nuclear medicine: official publication. Soc Nuclear Med. 2023;64:386\u201394. https:\/\/doi.org\/10.2967\/jnumed.122.264544.","journal-title":"Soc Nuclear Med"},{"key":"7495_CR11","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1007\/s00259-024-06626-9","volume":"51","author":"L Liu","year":"2024","unstructured":"Liu L, Zhong J, Zhang Z, Ye X, Wang X, Liu S. Preclinical study and first-in-human imaging of [(18)F]FAP-2286, and comparison with 2-[(18)F]FDG PET\/CT in various cancer patients. Eur J Nucl Med Mol Imaging. 2024;51:2012\u201322. https:\/\/doi.org\/10.1007\/s00259-024-06626-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7495_CR12","first-page":"55","volume":"1","author":"F Kouhen","year":"2024","unstructured":"Kouhen F, ElGouach H, Errafiy N. Review article: postoperative radiotherapy in resected non-small cell lung cancer: current status and enduring challenges in 2024. Gulf J Oncol. 2024;1:55\u201360.","journal-title":"Gulf J Oncol"},{"key":"7495_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/mnm.0000000000001990","author":"H Zhang","year":"2025","unstructured":"Zhang H, Pang L, Hou J, Li B, Zhang Y. Significance of 18F-fluorodeoxyglucose pet\/computed tomography in the initial staging of malignant peritoneal mesothelioma. Nucl Med Commun. 2025. https:\/\/doi.org\/10.1097\/mnm.0000000000001990.","journal-title":"Nucl Med Commun"},{"key":"7495_CR14","doi-asserted-by":"publisher","unstructured":"Mingels C, Madani MH, Sen F, Nalbant H, Riess JW, Abdelhafez YG, et al. Diagnostic accuracy in NSCLC lymph node staging with total-body and conventional PET\/CT. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07177-3.","DOI":"10.1007\/s00259-025-07177-3"},{"key":"7495_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.semnuclmed.2025.01.002","volume":"55","author":"C Sathekge","year":"2025","unstructured":"Sathekge C, Maes J, Maes A, Van de Wiele C. FDG PET\/CT for staging lung carcinoma: an update. Semin Nucl Med. 2025;55:167\u201374. https:\/\/doi.org\/10.1053\/j.semnuclmed.2025.01.002.","journal-title":"Semin Nucl Med"},{"key":"7495_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s00259-019-04346-z","volume":"46","author":"FL Giesel","year":"2019","unstructured":"Giesel FL, Heussel CP, Lindner T, R\u00f6hrich M, Rathke H, Kauczor H-U, et al. FAPI-PET\/CT improves staging in a lung cancer patient with cerebral metastasis. Eur J Nucl Med Mol Imaging. 2019;46:1754\u20135. https:\/\/doi.org\/10.1007\/s00259-019-04346-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7495_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/jpm11020133","volume":"11","author":"JP Pijl","year":"2021","unstructured":"Pijl JP, Kwee TC, Slart RHJA, Glaudemans AWJM. PET\/CT imaging forpersonalized management of infectious diseases. J Pers Med. 2021;11:133. https:\/\/doi.org\/10.3390\/jpm11020133.","journal-title":"J Pers Med"},{"key":"7495_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.lungcan.2021.05.003","volume":"157","author":"JMM Rogasch","year":"2021","unstructured":"Rogasch JMM, Frost N, Bluemel S, Michaels L, Penzkofer T, von Laffert M, et al. FDG-PET\/CT for pretherapeutic lymph node staging in non-small cell lung cancer: a tailored approach to the ESTS\/ESMO guideline workflow. Lung Cancer. 2021;157:66\u201374. https:\/\/doi.org\/10.1016\/j.lungcan.2021.05.003.","journal-title":"Lung Cancer"},{"key":"7495_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40644-024-00701-y","volume":"24","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang Y, Guo Z, Hou P, Lv J, Ke M, et al. [(18)F]FAPI adds value to [(18)F]FDG PET\/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study. Cancer Imaging: Official Publication Int Cancer Imaging Soc. 2024;24:68. https:\/\/doi.org\/10.1186\/s40644-024-00701-y.","journal-title":"Cancer Imaging: Official Publication Int Cancer Imaging Soc"},{"key":"7495_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00259-023-06404-z","volume":"51","author":"S Ballal","year":"2023","unstructured":"Ballal S, Yadav MP, Roesch F, Satapathy S, Moon ES, Martin M, et al. Head-to-head comparison of [(68)Ga]Ga-DOTA.SA.FAPi with [(18)F]F-FDG PET\/CT in radioiodine-resistant follicular-cell derived thyroid cancers. Eur J Nucl Med Mol Imaging. 2023;51:233\u201344. https:\/\/doi.org\/10.1007\/s00259-023-06404-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7495_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1413771","volume":"14","author":"F Xiang","year":"2024","unstructured":"Xiang F, Zhang Y, Tan X, Zhang J, Li T, Yan Y, et al. Comparison of (68)Ga-FAP-2286 and (18)F-FDG PET\/CT in the diagnosis of advanced lung cancer. Front Oncol. 2024;14: 1413771. https:\/\/doi.org\/10.3389\/fonc.2024.1413771.","journal-title":"Front Oncol"},{"key":"7495_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/mnm.0000000000001913","author":"X Mu","year":"2024","unstructured":"Mu X, Lu L, Li J, Zhang L, Deng Y, Fu W. Low false-positive lymph nodes for 18F-fibroblast activation protein inhibitors pet\/computed tomography in preoperative staging of patients with nonsmall cell lung cancer. Nucl Med Commun. 2024. https:\/\/doi.org\/10.1097\/mnm.0000000000001913.","journal-title":"Nucl Med Commun"},{"key":"7495_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06976-4","author":"H Yuan","year":"2024","unstructured":"Yuan H, Chen X, Zhao X, Dai M, Liu Y, Han J, et al. A head-to-head comparison of [(68)Ga]Ga-DOTA-FGFR1 and [(18)F]FDG PET\/CT in the diagnosis of lung cancer. Eur J Nucl Med Mol Imaging. 2024. https:\/\/doi.org\/10.1007\/s00259-024-06976-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7495_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16172954","author":"D Guedj","year":"2024","unstructured":"Guedj D, Neve\u00fc S, Becker M, Mermod M. FDG PET-CT for the detection of occult nodal metastases in head and neck cancer: a systematic review and meta-analysis. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16172954.","journal-title":"Cancers (Basel)"},{"key":"7495_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/mnm.0000000000001866","volume":"45","author":"Y Hu","year":"2024","unstructured":"Hu Y, Guo D, Zhu Z, Lu L, Jia Z, Li W, et al. The value of dual time-point fluorine-18 fluorodeoxyglucose PET\/computed tomography imaging in predicting lymph node metastasis in non-small cell lung cancer patients. Nucl Med Commun. 2024;45:812\u20137. https:\/\/doi.org\/10.1097\/mnm.0000000000001866.","journal-title":"Nucl Med Commun"},{"key":"7495_CR26","doi-asserted-by":"publisher","unstructured":"Ershadifar S, Larsson J, Young K, Abouyared M, Bewley A, Birkeland AC. Efficacy of (18)FDG-PET\/CT in detecting synchronous malignancies in patients with head and neck cancer: A systematic review and Meta-analysis. Otolaryngol\u2013Head Neck Surg. 2024. https:\/\/doi.org\/10.1002\/ohn.879","DOI":"10.1002\/ohn.879"},{"key":"7495_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01494-9","volume":"29","author":"Y Sun","year":"2024","unstructured":"Sun Y, Sun Y, Li Z, Song S, Wu K, Mao J, et al. (18)F-FAPI PET\/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with (18)F-FDG PET\/CT. Eur J Med Res. 2024;29: 9. https:\/\/doi.org\/10.1186\/s40001-023-01494-9.","journal-title":"Eur J Med Res"},{"key":"7495_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.acra.2024.09.026","author":"QC Wan","year":"2024","unstructured":"Wan QC, Bai L, Wang ZY, Ji B. Diagnostic performance of FAPI PET\/CT for the detection of lymph node metastases in lung cancer patients: a meta-analysis. Acad Radiol. 2024. https:\/\/doi.org\/10.1016\/j.acra.2024.09.026.","journal-title":"Acad Radiol"},{"key":"7495_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/radiol.211424","volume":"303","author":"L Wang","year":"2022","unstructured":"Wang L, Tang G, Hu K, Liu X, Zhou W, Li H, et al. Comparison of (68)Ga-FAPI and (18)F-FDG PET\/CT in the evaluation of advanced lung cancer. Radiology. 2022;303:191\u20139. https:\/\/doi.org\/10.1148\/radiol.211424.","journal-title":"Radiology"},{"key":"7495_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.924223","volume":"12","author":"J Wu","year":"2022","unstructured":"Wu J, Deng H, Zhong H, Wang T, Rao Z, Wang Y, et al. Comparison of (68)Ga-FAPI and (18)F-FDG PET\/CT in the evaluation of patients with newly diagnosed non-small cell lung cancer. Front Oncol. 2022;12: 924223. https:\/\/doi.org\/10.3389\/fonc.2022.924223.","journal-title":"Front Oncol"},{"key":"7495_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00330-023-10013-7","volume":"34","author":"Q Yang","year":"2024","unstructured":"Yang Q, Huang D, Wu J, Zhong H, Han Y, Jiang H, et al. Performance of [(18)F]FDG PET\/CT versus FAPI PET\/CT for lung cancer assessment: a systematic review and meta-analysis. Eur Radiol. 2024;34:1077\u201385. https:\/\/doi.org\/10.1007\/s00330-023-10013-7.","journal-title":"Eur Radiol"},{"key":"7495_CR32","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1007\/s00259-022-06048-5","volume":"50","author":"Z Rao","year":"2023","unstructured":"Rao Z, Zhang Y, Liu L, Wang M, Zhang C. [(177)Lu]Lu-FAP-2286 therapy in a case of right lung squamous cell carcinoma with systemic metastases. Eur J Nucl Med Mol Imaging. 2023;50:1266\u20137. https:\/\/doi.org\/10.1007\/s00259-022-06048-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7495_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/rlu.0000000000005169","volume":"49","author":"H Yang","year":"2024","unstructured":"Yang H, Liu H, Zhang Y, Zhang Y, Chen Y. Metastatic lung adenocarcinoma received combined 177Lu-FAP-2286 radiation therapy and targeted therapy. Clin Nucl Med. 2024;49:569\u201371. https:\/\/doi.org\/10.1097\/rlu.0000000000005169.","journal-title":"Clin Nucl Med"},{"key":"7495_CR34","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00259-023-06211-6","volume":"50","author":"D Zboralski","year":"2023","unstructured":"Zboralski D, Osterkamp F, Christensen E, Bredenbeck A, Schumann A, Hoehne A, et al. Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition. Eur J Nucl Med Mol Imaging. 2023;50:2621\u201335. https:\/\/doi.org\/10.1007\/s00259-023-06211-6.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07495-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07495-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07495-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:15Z","timestamp":1769222775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07495-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7495"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07495-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and approval was granted by the Ethics Committee of the first affiliated hospital of China Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\u00a0and publish"}},{"value":"The authors have no interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}